Elanco Animal Health Incorporated (ELAN) — closed signal from August 31, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on November 29, 2025.
Predicted vs. what happened
What happened
Reached its target in 37 days.
The thesis — published August 31, 2025
Elanco's stock trend is improving, and the price recently moved above what many analysts expected. Buying interest is strong, and animal health often holds up when markets get cautious. As the company refines its portfolio, profits can scale faster. Optimism is slightly ahead of results, but buying near 17.60 to 18.50 can work for a 1 to 3 month hold as steady momentum and gradually rising estimates continue.
Primary drivers
- Price moved above typical analyst targets, showing improving sentiment.
- Stronger than its recent average price, showing buyers are active.
- Animal health is a steady, defensive business with room to grow further.
- Positive mood ahead of results may lift shares a bit in the near term.
How it played out
ELAN: target reached in 37 days
Lyra published ELAN at 18.35 on 2025-08-31, with an 18% expected gain and a 21.65 target. The thesis pointed to improving stock trend, stronger buying interest, a move above typical analyst targets, defensive animal health exposure, portfolio refinement, and a positive mood ahead of results. It also noted that optimism was slightly ahead of results.
Inside the window, the stock reached the target in 37 days. It later peaked at 23.70 on 2025-11-26, with a 29.2% peak gain. The window ended at 23.27, still above the target. The published thesis played out.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.